ABSTRACT-The possibility that hyperlipidemia and an increase of mononuclear cells in the glomeruli could participate in the pathogenesis of minimal change glomerulopathy was evaluated in puromycin aminonucleoside (PAN) nephrosis in rats. Significant increases in intraglomerular CD4-, IL-2-receptor(R) -and ED-1-positive cells were found in PAN rats. Urinary protein excretion and mononuclear cells in the glomeruli of 1% cholesterol diet-fed rats significantly increased, compared with standard diet feeding. Moreover, administration of a subnephrogenic dose of PAN in cholesterol diet-fed rats substantially in creased urinary protein excretion and mononuclear cells in the glomeruli. Additionally, antihyperlipidemia agents and immunosuppressive agents prevented urinary protein excretion and increases of CD4-, IL-2R -and ED-1-positive cells in the glomeruli of PAN nephrotic rats. Monoclonal antibodies directed against these cells also prevented urinary protein excretion. These results suggest that CD4-, IL-2R-and ED-1 -positive cells and hyperlipidemia are involved in the progression, but not the pathogenesis, of PAN.
The nephrotic syndrome, characterized by severe pro teinuria hypoproteinemia, edema formation and hyper lipidemia is a consequence of altered permselectivity of the glomerular filtration barrier. The administration of puromycin aminonucleoside (PAN) to rats results in mas sive proteinuria due to well-defined glomerular lesions which are similar in many aspects to human minimal change nephropathy (1) . It has been widely accepted that nonimmune mechanisms such as reactive oxygen species may be important in the pathogenesis of this experimental nephrosis (2, 3) . However, recent reports indicated that bone marrow-derived cell depletion by X-ray irradiation or essential fatty acid deficiency improved renal function and glomerular injury of PAN nephrosis (4, 5) . In addi tion, it has been reported that the supernatant of con canavalin A-stimulated peripheral mononuclear cells from human minimal change nephrotic syndrome was capable of inducting proteinuria in rats (6) . Accordingly, contribution of cellular immunity abnormalities in this model has been suggested.
On the other hand, a number of investigations have suggested that alterations in lipid metabolism may be im portant in the pathogenesis of progressive renal injury in human and experimental glomerulonephropathy (7 9). Diet-induced hypercholesterolemia has been shown to cause renal injury in rats (10), rabbits (11) and guinea pigs (12). Moreover, increases in the numbers of monocytes and macrophages in the glomeruli of rats with hypercho lesterolemia have been observed (7, 8) . Moreover, it has also been reported that excess cholesterol amplifies sev eral macrophage functions including phagocytosis, adhe sion to endothelium and secretion of chemotactic and mitogenic substances (13, 14) . Here, we investigated whether mononuclear cells in the glomeruli are associated with the progression of glomeru lar injury in PAN nephrosis. In the first experiment, we monitored changes in the numbers of leukocyte-subsets during the course of PAN nephrosis. In the second ex periment, the effects of antihyperlipidemia agents and immunosuppressive agents on urinary protein excretion in PAN nephrosis were evaluated. In addition, we inves tigated which mononuclear cell is associated with the progression of PAN nephrosis. In the third experiment, effects of W3/25, OX-39 and ED-1 monoclonal anti bodies directed against the surface antigens of CD4 (Helper/Helper inducer T cell), IL-2-receptor (R) and monocytes/macrophages on the proteinuria in rats with PAN nephrosis were also investigated.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley strain rats, weighing approx. 200 g (Nihon SLC, Hamamatsu), were used for all experi ments. They were housed in groups of four to five under a 12-hr light-dark cycle with food and water freely avail able.
Drugs
Cholestyramine (Bristol-Myers Squibb Co., Ltd., Tokyo), simfibrate (Maruko Chemical Co., Ltd., Nagoya), cyclo sporin A (Sandoz, Tokyo) and azathioprine (Sigma Chemical Co., St. Louis, MO, USA) were used. Chole styramine and simfibrate were suspended in distilled water. Cyclosporin A was dissolved in olive oil with 1 % ethanol. Azathioprine was suspended in 1 % gum arabic. Puromycin aminonucleoside (PAN) was purchased from Sigma Chemical Co.
Experimental protocol
To determine the time course of the number of leuko cyte-subsets in the glomeruli after the administration of PAN, 20 animals (N=5) were given 10 mg/100 g BW of PAN by intraperitoneal injection. The numbers of leukocyte subsets were determined for the kidneys on the 1st, 4th, 8th and 11th day after the administration of PAN. Tissues for immunoenzymatic staining were frozen in liquid nitrogen as described below.
To investigate the effect of hyperlipidemia on the num ber of leukocyte-subsets in the glomeruli of PAN nephro sis, age-matched animals were fed either a standard rat chow or a 1 % cholesterol-supplemented diet (Chubu Science Materials, Nagoya). The animals were main tained on the diet for at least 2 weeks before use in the experiment. The rats were given 5 mg/100 g BW of PAN as a subnephrogenic dose. The urinary protein excretion and the number of leukocyte-subsets were determined at various time intervals.
To examine the effects of inhibiting the hyperlipidemia and the increase in the number of leukocyte-subsets in the glomeruli in this model, rats were treated with a lipid lowering agent and an immunosuppressive agent for 11 days after the administration of PAN. Cholestyramine (1,000 mg/kg/day, p.o.), simfibrate (1,000 mg/kg/day, p.o.), cyclosporin A (20 mg/kg/day, p.o.) and azathio prine (50 mg/kg/day, p.o.) were administered to 7 rats from 5 min after the administration of PAN to 11th day. The remaining group was orally given the vehicle instead of the test drugs and served as the control. In addition, for the control, normal animals were treated according to the above schedule but given saline instead of PAN. Urine was collected over a 24-hr period in metabolic cages on the 4th, 7th and 11th day after PAN injection. Blood was also collected on the 12th day.
Urine and blood parameters At the beginning of the urine collection, each animal orally received 8 ml of distilled water without feeding. The collected urine was then centrifuged at 3,000 rpm for 10 min, and the supernatant was used for protein deter mination. Immediately after the urine collection, 0.4 ml of blood was drawn from the tail vein of each of the conscious animals with a disposable microsyringe and put into a tube containing 0.025 ml of heparin (1,000 U/ml). The blood was centrifuged at 5,000 rpm to obtain plasma for the determination of cholesterol and creatinine con tents.
Determination
of urinary protein, plasma cholesterol, triglyceride and creatinine contents
The urinary protein excretion was determined by the method of Kingsbury et al. (15) and the results are expressed as mg/24-hr urine. The cholesterol and triglyceride con tents were determined by cholesterol and triglyceride determination kits (Detamina TC-5 and TG-5; Kyowa Medex Co., Ltd., Tokyo). The creatinine content was determined by a creatinine determination kit (CRE EN; Kainos Lab. Inc., Tokyo).
Monoclonal antibodies
Mouse monoclonal antibodies (Serotec Co., Ltd., Oxford, England) against rat leukocyte subpopulations used in this study were as follows: OX-1 (leukocyte com mon antigen), W3/25 (helper/helper inducer T cells), ED-1 (most macrophages and some dendritic cells), OX-8 (cytotoxic/suppressor T cell), OX-39 (IL-2-receptor positive cells) and RT1.B (la-positive cells).
Immunohistochemistry
Tissues for immunoenzymatic staining were fixed in paraformaldehyde-lysine-periodate (16). Serial cryostat sections were adhered on microscope slides, air-dried and preincubated with 1-2% normal horse serum in phos phate-buffered saline (PBS) for 20 min. Sections were then incubated with mouse anti-rat monoclonal anti bodies for 90 min, washed twice in PBS, treated with 0.3% hydrogen peroxide in methanol for 40 min to block endogenous peroxidase, and incubated with biotinated affinity purified anti-mouse IgG and avidinated horse radish peroxidase with diaminobenzidine tetrahydrochlo ride. The above procedures were carried out by Vecta stain ABC kit (Vector Laboratories, Inc., Burlingame, CA, USA). All steps were performed at room tempera ture.
Quantification of leukocytes on tissue sections
Labelled cells within each glomerulus were counted by an image analyzer (Toyobo V1; Toyobo Co., Ltd., Tokyo) and the results are expressed as the number of cells per glomerular cross section (17). Cell counts were performed three times to reduce counting errors.
Effects of CD4-, IL-2R and ED-.1-positive cells depletion on PAN nephrosis W3/25, OX-39 and ED-1 monoclonal antibodies against CD4 antigen, IL-2R and ED-1 antigen, respectively, were used to deplete these cells. These antibodies were diluted tenfold with PBS, and 0.5 ml of diluted monoclonal anti body (0.48 mg of immunoglobulin fraction) was daily administered to the rats with PAN nephrosis by intra venous injection from the day after the PAN injection to the 11th day. The nephrotic control animals and nor mal control were injected with 0.48 mg of normal mouse immunoglobulin.
This amount of monoclonal antibodies was capable of reducing the number of each type of cell in the glomeruli by approx. 80%, when these antibodies were injected in travenously in the rats 15th day at once (18). Inhibitory percentage (°10) =(Control -Test drugs) x 100 / (Control-Normal)
RESULTS
Time course of the changes in the number of leukocyte subsets in glomeruli of rats with PAN nephrosis Urinary protein excretion, plasma cholesterol and triglyceride ( Fig. 1) : The urinary protein excretion in the PAN nephrosis significantly increased from the 6th day to the 11th day after PAN injection. Plasma choles terol and triglyceride contents in the PAN nephrotic group were also elevated from the 9th day. Total leukocyte (leukocytes common antigen) and total lymphocyte (CD3) (Fig. 2) : A significant increase in the number of total leukocytes labelled by OX-1 and total lymphocytes labelled by OX-19 on the 7th day were seen in the glomeruli of rats with PAN nephrosis (P<0.01). Macrophages/monocytes and Ia positive cells (Fig. 3B ): Macrophages/monocytes numbers, as labelled by ED-1 monoclonal antibody, in the glomeruli of PAN nephrotic rats were significantly increased on the 7th day and 11th day. However, the number of la-positive cells labelled by RT1.B monoclonal antibody in the glomeruli of PAN nephrotic rats did not alter during the experimental period. Effect of 1 % cholesterol diet on subnephrogenic dose of PAN (Figs. 4 and 5 ): Urinary protein excretion in 1010 cholesterol diet rats was significantly higher than that of standard diet rats, throughout the experimental period. By the 7th day after the administration of a subnephro genic dose of PAN, the 1010 cholesterol diet rats showed an increase in urinary protein excretion (Fig. 4) . This increase was statistically not significant, but the great F ratios (P < 0.01) show that the 1010 cholesterol diet poten tiated the effect of PAN in one or a few animals of each group. The numbers of CD4-, IL-2R-positive cells and macrophage/monocyte in 1010 cholesterol diet rats with the subnephrogenic dose of PAN were significantly higher than those in rats with only the subnephrogenic dose of PAN. These cells in the glomeruli of the I To cholesterol diet rats also increased, compared with those of standard diet rats (Fig. 5) . The cholesterol content in both the 1 % cholesterol group and 1010 cholesterol with the sub nephrogenic dose of PAN was significantly increased, hibited excretion by the 7th day.
Effects of cholestyramine, simfibrate, azathioprine and cyclosporin A on the number of CD4-, IL-2R-positive cells and macrophage/monocyte in PAN nephrosis (Table  1) Effects of monoclonal antibodies against ED-1, IL-2R and CD4 on urinary protein excretion in PAN nephrosis in rats (Fig. 8) The urinary protein excretion of nephrotic control was markedly increased by the 7th day. In contrast, the ad ministration of ED-1 monoclonal antibody resulted in a marked attenuation of increased proteinuria. In addition, the antinephrotic effect of monoclonal antibody against IL-2 receptors was stronger than that of ED-1 monoclonal antibody. compared with each control (data not shown).
Effects of cholestyramine, simfibrate, azathioprine and cyclosporine A on proteinuria (Figs. 6 and 7) Cholestyramine at 1,000 mg/kg/day, p.o. prevented the urinary protein excretion by the 7th day. Simfibrate at 1,000 mg/kg/day, p.o. also prevented the urinary pro tein excretion by the 11th day. Cyclosporin A at 20 mg /kg/day, p.o. prevented the urinary protein excretion by the 4th day. Azathioprine (50 mg/kg/day) treatment in The present study demonstrated that the number of CD4-, IL-2R and ED-1-positive cells significantly in creased in the glomeruli of rats with PAN nephrosis. However, in the present study, proteinuria was the earli est clinical manifestation in the course of PAN nephrosis. Therefore, it is likely that the accumulation of these cells in the glomeruli is secondary to PAN-induced alteration. There has been no evidence to suggest that PAN has a direct effect on mononuclear cells or it affects immuno logic function. However, Schreiner et al. (21) noted that ultrastructural evidence of epithelial cell dysfunction is followed by an increase in the number of leukocytes in the glomeruli. Thus, it is controversial that leukocytes, including CD4-, IL-2R and ED-1-positive cells, are involved in the development of PAN nephrosis.
On the other hand, recent studies have indicated that the abnormalities in lipid metabolism may be important in the pathogenesis of progressive renal injury in human and experimental glomerulonephropathy (7, 8) . Clofibric acid, an antihyperlipidemic agent, ameliorated the degree of the renal injury in rats with reduced renal mass and the obese Zucker rat model of endogenous hyperlipidemia (22, 23). In addition, many reports (9-11) demonstrated that renal injury is caused by a cholesterol-supplemented diet. These findings likely support the hypothesis that hyperlipidemia in the nephrotic syndrome may be as sociated with progression of glomerular injury.
It is well-known that macrophages are important in the pathogenesis of atherosclerosis. It has been believed that atherosclerosis may be induced by which macrophages accumulate on the cholesterol-fixed endothelial cells in the vessel. On the other hand, the long term experiments on PAN nephrosis have documented that focal and seg mental sclerosis in the glomeruli is observed by 90 days after PAN injection. Therefore, it is likely that macro phages may play a crucial role in the development of glomerular injury in PAN nephrosis as well as atheroscle rosis. Kasiske et al. (22) reported that the cholesterol sup plemented diet-fed rats had a greater amount of macro phages/monocytes and T lymphocytes in their glomeruli compared with those of standard diet-fed rats. Diamond et al. also demonstrated that peritoneal macrophages in PAN nephrosis exhibited enhanced phagocytic activity and thromboxane A2 release (14). Although those find ings suggest the possibility that hyperlipidemia may be associated with progression of glomerular injury through the macrophage functions which are enhanced by PAN nephrosis, the present results indicated that mononuclear cell accumulation in the glomeruli occurred earlier than hyperlipidemia. Thus, the relationship between hyper lipidemia and mononuclear cells is obscure in PAN nephrosis. in the preliminary experiment, we did not observe any effect to reduce the cholesterol level using 750 mg/kg of these drugs in PAN nephrosis rats for 2 weeks (data not shown). Therefore, we administered such a higher dose of each antihyperlipidemic agent to produce a lower level of the cholesterol in a short period. PAN nephritic rats did not appear to suffer from adverse effects throughout the experimental period.
Treatment with azathioprine and cyclosporin A im proved the urinary protein excretion and increases in the numbers of CD4-, IL-2R and ED-1-positive cells. Azathioprine and cyclosporin A also inhibited the in creases in plasma cholesterol and creatinine contents in PAN nephrosis (data not shown). However, the inhibi tory effects of immunosuppressive agents on urinary pro tein excretion and increase in mononuclear cell number were less than those of antilipidemic agents. These results suggest the mechanisms by which T lymphocytes and macrophages were activated by hyperlipidemia may be antigen-non-specific rather than antigen-specific. The depleting leukocyte study with monoclonal anti bodies demonstrated that increases in the numbers of CD4-, IL-2R and ED-1-positive cells substantially are associated with the progression of PAN nephrosis. Monoclonal antibodies against the three surface antigens prevented urinary protein excretion. However, W3/25 monoclonal antibody (against CD4) had not prevented the urinary protein excretion by the 11th day. These results suggest that the increase in the number of acti vated helper T cells bearing IL-2R and macrophages in the glomeruli may play more important role in the pro gression of PAN nephrosis than the increase in nonacti vated helper T cells.
In conclusion, we propose that the activation of these cells is caused by hyperlipidemia in the nephrotic syn drome and the accumulation of these cells in the glomeruli is associated with the progression of glomerular injury. However, further investigation is required to elucidate where macrophages and T lymphocytes could be activated in PAN nephrosis rats; namely, it is unclear whether these cells are activated in the circulation or in the glomeruli.
